openPR Logo
Press release

Oral Solid Dosage Pharmaceutical Formulation Market is expected to grow at 7.10% through 2021 to 2027, reaching nearly USD 957.55 Bn.

Oral Solid Dosage Pharmaceutical Formulation Market

Oral Solid Dosage Pharmaceutical Formulation Market

29.8.2023: Oral Solid Dosage Pharmaceutical Formulation Market Report Scope and Research Methodology

Report Scope:

The report's purview encompasses market trends from 2017, forecasting through 2027. With 2021 as the base year, actual figures for that year derive from the market's real output. Furthermore, special attention is given to the effects of lockdowns on demand, supply, and the consequential impact over the next two years. Amidst the lockdown challenges, the report delves into the strategic analysis of companies that managed to thrive during this period.

Research Methodology:

To ensure accuracy and credibility, the report's research methodology underscores its findings. Those seeking insights into the methodology can avail themselves of a free sample report.

For detail insights on this market, request for methodology here @ : https://www.maximizemarketresearch.com/market-report/oral-solid-dosage-pharmaceutical-formulation-market/121388/

What are Oral Solid Dosage Pharmaceutical Formulation Market Dynamics?

Market Drivers:

The oral solid dosage pharmaceutical formulation market's ascension can be attributed to its fundamental role in pharmaceuticals. This method, known for its simplicity and cost-effectiveness, facilitates precise dosing for various acute and chronic ailments. The ease of manufacturing, packaging, and transport adds to its appeal, fuelling its global growth prospects.

Market Restraints:

While the potential for growth is significant, certain constraints exist. The initial cost of implementing such formulations and the lack of technical knowledge might temper market penetration. However, the industry's overall trajectory remains optimistic.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ : https://www.maximizemarketresearch.com/request-sample/121388

Oral Solid Dosage Pharmaceutical Formulation Market Segmentation?

The market for pharmaceutical products for oral solid dosage is expected to rise alongside the tablet sector.

With a market share of 55.6% in 2021, the tablet segment is in absolute dominance. A tablet is a type of solid dosage form used in medicine. A solid unit dosage form of a pharmaceutical, or a combination of medications with the proper excipients, is referred to as a tablet. It is composed of an active agent and excipient powder mixture that has been crushed or pressed into a solid dose. Additionally, tablets come in a variety of sizes and shapes and have a long lifespan. Additionally, they have a higher capacity for an active ingredient than a capsule.

The Oral Solid Dosage Pharmaceutical Formulation Market is expanding with the help of the Extended Release segment.

Oral extended-release drugs are substances that alter when or how quickly a drug substance is released. In older modified-release medicines, subcutaneous and intramuscular injections of solutions of insoluble drug complexes were prevalent. Furthermore, new oral modified release dose dose Formulations have been created as a result of technical breakthroughs. Oral extended-release tablets are referred to by a variety of terms, including modified release, prolonged release, controlled release, and sustained release. The benefits of oral extended-release tablets over conventional dosage forms, as well as increased research and development for these products, will soon drive the market for oral extended-release tablets.

Who are Oral Solid Dosage Pharmaceutical Formulation Market Key Players?

• Takeda Pharmaceutical Company Limited
• Merck & Co., Inc., d.b.a
• Corealis Pharma Inc.
• Astellas Pharma Inc.
• CordenPharma International
• Bayer AG
• AbbVie Inc.
• Thermo Fisher Scientific Inc. (Patheon N.V.)
• Lonza
• Catalent Inc.
• Alcami Corporation
• Halo Pharmaceutical Inc.
• CordenPharma International
• Arnet Pharmaceuticals
• Jubilant Life Sciences
• Pfizer Inc.
• Piramal EnterprisesLtd
• Metrics Contract Services
• GENVION Corporation
• GlaxoSmithKline plc.
• CMIC HOLDINGS Co., LTD.
• Tower Laboratories Ltd.
• PNP Pharmaceuticals Inc.
• Confab Laboratories Inc.
• Wockhardt Ltd.
• Pharma Tech Industries

Please connect with our representative, who will ensure you to get a report sample here @ : https://www.maximizemarketresearch.com/request-sample/121388

Regional Insights:

Leading the market is North America, which held the highest revenue share in 2021. With a predicted CAGR of 6.7%, the region is expected to continue its profitable streak. Factors such as a consolidating pharmaceutical industry, outsourcing expansion, advanced infrastructure, and manufacturing technologies contribute to this growth trend. The United States, Canada, and Mexico dominate North America, with increasing consumer awareness about sustained release and controlled release tablets propelling market expansion.

Key Offerings:

Past Market Size and Competitive Landscape (2018 to 2021)
Past Pricing and price curve by region (2018 to 2021)
Market Size, Share, Size & Forecast by different segment | 2022-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

Related Reports:

Coffee Shop Market:https://www.maximizemarketresearch.com/market-report/global-coffee-shop-market/113030/

Global Food Texture Market:https://www.maximizemarketresearch.com/market-report/global-food-texture-market/117857/

Go Kart Market:https://www.maximizemarketresearch.com/market-report/go-kart-market/124634/

Global Smoked Fish Market:https://www.maximizemarketresearch.com/market-report/global-smoked-fish-market/147525/

Jute Bags Market: https://www.maximizemarketresearch.com/market-report/jute-bags-market/146633/

Global Western Wear Market: https://www.maximizemarketresearch.com/market-report/global-western-wear-market/21925/

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.

444 West Lake Street, Floor 17,

Chicago, IL, 60606, USA.

+1 800 507 4489 +91 9607365656

sales@maximizemarketresearch.com

www.maximizemarketresearch.com

About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oral Solid Dosage Pharmaceutical Formulation Market is expected to grow at 7.10% through 2021 to 2027, reaching nearly USD 957.55 Bn. here

News-ID: 3185597 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Biomethane Market Size, Share, and Global Growth Forecast (2026-2032)
Biomethane Market Size, Share, and Global Growth Forecast (2026-2032)
Biomethane Market size was valued at USD 5.93 Billion in 2025 and the total Biomethane revenue is expected to grow at a CAGR of 6.08% from 2026 to 2032, reaching nearly USD 8.96 Billion. Biomethane Market Overview: The biomethane market has emerged as an essential pillar of the world's transition toward a circular economy and net-zero energy networks. Valued at a substantial USD 5.93 Billion in 2025, the total global revenue of
Water Treatment Chemicals Market Size, Share, and Global Growth Forecast (2026-2032)
Water Treatment Chemicals Market Size, Share, and Global Growth Forecast (2026-2 …
Water Treatment Chemicals Market size was valued at USD 39.98 Bn. in 2025, and the total Water Treatment Chemicals Market revenue is expected to grow by 4.83% from 2026 to 2032, reaching nearly USD 55.62 Bn. Water Treatment Chemicals Market Overview: The global water treatment chemicals market represents a critical and foundational backbone within public municipal infrastructure, modern industrial operations, and environmental conservation frameworks. Valued at a substantial USD 39.98 Billion in
Paints and Coatings Market to Hit USD 294.82 Billion by 2032 at 4.16% CAGR
Paints and Coatings Market to Hit USD 294.82 Billion by 2032 at 4.16% CAGR
Paints and Coatings Market size was valued at USD 221.64 Billion in 2025 and the total Paints and Coatings revenue is expected to grow at a CAGR of 4.16% from 2025 to 2032, reaching nearly USD 294.82 Billion by 2032. Paints and Coatings Market Overview: The paints and coatings market represents a foundational and highly diverse sector operating at the intersection of heavy manufacturing, chemical engineering, and urban real estate. Valued at
Mesh App and Service Architecture Market Size, Share, and Global Forecast (2025-2032)
Mesh App and Service Architecture Market Size, Share, and Global Forecast (2025- …
Mesh App and Service Architecture Market size was valued at USD 3.46 Billion in 2025 and the total revenue is expected to grow at a CAGR of 5% from 2025 to 2032, reaching nearly USD 4.87 Billion. Mesh App and Service Architecture Market Overview: The mesh app and service architecture market represents a highly specialized foundational vertical within the modern enterprise software and cloud native computing landscapes. Valued at a substantial USD

All 5 Releases


More Releases for Pharma

Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring